Results 41 to 50 of about 7,568,653 (278)
Evaluation of liver stiffness measurement–based scores in liver transplantation recipients
Abstract Combining bioclinical parameters with liver stiffness measurement (LSM) has improved the diagnostic performance of vibration‐controlled transient elastography (VCTE) for detection of advanced fibrosis in patients with chronic liver disease. However, this approach has not yet been tested in liver transplantation (LT) recipients.
Tamoore Arshad +11 more
wiley +1 more source
ASSOCIATION OF ANTHROPOMETRIC AND BIOCHEMICAL PARAMETERS WITH NONALCOHOLIC FATTY LVER DISEASE
Objective: To study the association of anthropometric and biochemical parameters with nonalcoholic fatty liver disease (NAFLD) diagnosed on ultrasonography (USG). Study Design: Cross sectional analytical study.
Muhammad Usman Munir +3 more
doaj +4 more sources
Pharmacotherapy for Nonalcoholic Fatty Liver Disease [PDF]
Lifestyle modifications and optimization of the management of cardiometabolic comorbidities are currently the mainstay of treatment for patients with nonalcoholic fatty liver disease.
Chalasani, Naga, Gawrieh, Samer
core +1 more source
Abstract End‐ischemic viability testing by normothermic machine perfusion (NMP) represents an effective strategy to recover liver grafts having initially been discarded for liver transplantation (LT). However, its results in the setting of significant (≥30%) macrovesicular steatosis (MaS) have not been specifically assessed.
Damiano Patrono +8 more
wiley +1 more source
Nonalcoholic Fatty Liver Disease in Children [PDF]
AbstractNonalcoholic steatohepatitis, a progressive form of nonalcoholic fatty liver disease (NAFLD), is one of the most common hepatic diseases in children who present with particular risk factors including obesity, sedentary lifestyle, and/or a predisposing genetic background.
Mann, Jake P. +4 more
openaire +5 more sources
Background/Aims: Nonalcoholic fatty liver disease is related to obesity, metabolic syndrome, and insulin resistance. Nonalcoholic fatty liver disease and metabolic syndrome may also be encountered in non-obese, non-diabetic individuals, and there are no ...
Gülbanu Erkan +5 more
doaj +1 more source
AimsWe aimed to explore the metabolic features of lean nonalcoholic fatty liver disease (Lean-NAFLD) and its association with the risk of incident type 2 diabetes in young and middle-aged people.MethodsWe conducted a retrospective cohort study of 3001 ...
Nong Li +7 more
doaj +1 more source
Background & aims. Some phytochemicals present in coffee have a potential antioxidant role which seems to protect the human body against cardiovascular diseases, liver disease and malignancies.
Ylse Gutiérrez-Grobe +6 more
doaj +1 more source
Spatiotemporal Multi‐Omic Mapping Reveals Liver‐Muscle Metabolic Crosstalk in Cancer Cachexia
The interactive CCAtlas platform delineates cross‐species, spatiotemporal, and sex‐specific molecular dynamics and metabolic rewiring across organs during cancer cachexia. Hepatic Gamt downregulation curtails hepatic creatine synthesis to trigger systemic creatine insufficiency and consequent skeletal muscle atrophy in LLC tumour‐bearing mice ...
Zihan Tian +12 more
wiley +1 more source
Assessment of cardiovascular risk in patients with gout and nonalcoholic fatty liver disease
Aim. Cardiovascular diseases are observed more frequently in patients with gout as compared to other rheumatologic pathologies. Methods and results.
S. I. Smiyan, S. V. Danchak
doaj +1 more source

